Faber, Erik B. http://orcid.org/0000-0002-0525-3774
Sun, Luxin http://orcid.org/0000-0001-5260-4664
Tang, Jian
Roberts, Emily http://orcid.org/0000-0001-6710-0530
Ganeshkumar, Sornakala http://orcid.org/0000-0001-5840-5818
Wang, Nan http://orcid.org/0000-0002-7869-3797
Rasmussen, Damien http://orcid.org/0000-0001-6828-8520
Majumdar, Abir http://orcid.org/0000-0002-3516-5855
Hirsch, Laura E. http://orcid.org/0000-0001-9230-8181
John, Kristen
Yang, An
Khalid, Hira http://orcid.org/0000-0001-8857-9683
Hawkinson, Jon E. http://orcid.org/0000-0001-5461-7071
Levinson, Nicholas M. http://orcid.org/0000-0003-4338-8087
Chennathukuzhi, Vargheese http://orcid.org/0000-0002-4178-146X
Harki, Daniel A. http://orcid.org/0000-0001-5950-931X
Schönbrunn, Ernst http://orcid.org/0000-0002-3589-3510
Georg, Gunda I. http://orcid.org/0000-0002-8900-9460
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (R61 HD099743, HHSN27520180007I, R01 HD080431, R61 HD099743)
Minnesota Ovarian Cancer Alliance (NA)
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32 GM008244, T32 GM132029, R01 GM121515)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | National Cancer Institute (F30 CA232303)
National Institute for General Medical Sciences
U.S. Department of Defense (W81XWH-19-1-0336, W81XWH-21-1-0674)
Fulbright Association (NA)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development
Article History
Received: 18 July 2022
Accepted: 12 May 2023
First Online: 3 June 2023
Competing interests
: E.B.F, N.W., J.E.H., and G.I.G. are listed as inventors for a provisional patent application covering the compounds described in this paper (US Provisional Patent Application Serial No. 63/357,473—THERAPEUTIC COMPOUNDS AND METHODS—Filed June 30, 2022 (case 2021–219 Allosteric Inhibitors of Cyclin-Dependent Kinase 2 (CDK2)). The remaining authors declare no competing interests.